Randomized, controlled clinical study to evaluate efficacy of novel indigenously designed controlled release flurbiprofen gel system for management of periodontal diseases

Neeraj C Deshpande, K M Bhat, G S Bhat, Anshula N Deshpande, Neeraj C Deshpande, K M Bhat, G S Bhat, Anshula N Deshpande

Abstract

Background: This randomized, controlled clinical study was planned to evaluate the use of anti-inflammatory drug flurbiprofen in the form of locally delivered controlled release gel in the treatment of periodontal disease.

Materials and methods: The flurbiprofen gel was indigenously prepared in the concentration of 0.3%. The 30 patients with localized periodontal pockets measuring ≥5 mm were randomly divided into three groups. The groups received flurbiprofen gel, flurbiprofen gel after prophylaxis, and placebo gel after oral prophylaxis, respectively. The clinical parameters for plaque and gingival inflammation were evaluated at baseline, 7(th) day, and 14(th) day.

Results: The results of the study suggested the statistically significant (P < 0.05) improvement in the gingival status of the patients with the use of flurbiprofen gel as an adjunct to scaling and root planing as compared to oral prophylaxis or gel alone.

Conclusion: The data demonstrated that the additional use of local drug delivery of flurbiprofen through gel media enhances the positive effects of scaling and root planing and helps in faster resolution of the inflammation.

Keywords: Biodegradable gel system; flurbiprofen; host modulation; local drug delivery; non-steroidal anti-inflammatory drugs; periodontal disease.

Conflict of interest statement

Conflict of Interest: None declared

References

    1. Dewhirst FE, Moss DE, Offenbacher S, Goodson JM. Levels of prostaglandin E2, thromboxane, and prostacyclin in periodontal tissues. J Periodontal Res. 1983;18:156–63.
    1. Feldman RS, Szeto B, Chauncey HH, Goldhaber P. Non-steroidal anti-inflammatory drugs in the reduction of human alveolar bone loss. J Clin Periodontol. 1983;10:131–6.
    1. Van Dyke TE. The management of inflammation in periodontal disease. J Periodontol. 2008;79:1601–8.
    1. Silness J, Loe H. Periodontal disease in pregnancy. ii. correlation between oral hygiene and periodontal condtion. Acta Odontol Scand. 1964;22:121–35.
    1. Loe H, Silness J. Periodontal disease in pregnancy. i. prevalence and severity. Acta Odontol Scand. 1963;21:533–51.
    1. Mombelli A, Rutar A, Lang NP. Correlation of the periodontal status 6 years after puberty with clinical and microbiological conditions during puberty. J Clin Periodontol. 1995;22:300–5.
    1. Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, et al. Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. J Periodontal Res. 1983;18:516–26.
    1. Seymour RA, Heasman PA. Tetracyclines in the management of periodontal diseases. A review. J Clin Periodontol. 1995;22:22–35.
    1. Choi DH, Moon IS, Choi BK, Paik JW, Kim YS, Choi SH, et al. Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis. J Periodontal Res. 2004;39:20–6.
    1. Brunsvold MA, Chaves ES, Kornman KS, Aufdemorte TB, Wood R. Effects of a bisphosphonate on experimental periodontitis in monkeys. J Periodontol. 1992;63:825–30.
    1. Heasman PA, Seymour RA, Kelly PJ. The effect of systemically-administered flurbiprofen as an adjunct to toothbrushing on the resolution of experimental gingivitis. J Clin Periodontol. 1994;21:166–70.
    1. Heasman PA, Seymour RA, Boston PF. The effect of a topical non-steroidal anti-inflammatory drug on the development of experimental gingivitis in man. J Clin Periodontol. 1989;16:353–8.
    1. Yewey GL, Tipton AJ, Dunn RL, Manardi EM, McEnvoy RM, et al. Evaluation of biodegradable subgingival delivery system for Flurbiprofen. J Dent Res. 1991;70:324.
    1. Howell TH, Fiorellini J, Weber HP, Williams RC. Effect of the NSAID piroxicam, topically administered, on the development of gingivitis in beagle dogs. J Periodontal Res. 1991;26:180–3.
    1. Guimarães MR, Coimbra LS, de Aquino SG, Spolidorio LC, Kirkwood KL, Rossa C., Jr Potent anti-inflammatory effects of systemically administered curcumin modulate periodontal disease in vivo. J Periodontal Res. 2011;46:269–79.
    1. Elkhouli AM. The efficacy of host response modulation therapy (omega-3 plus low-dose aspirin) as an adjunctive treatment of chronic periodontitis (clinical and biochemical study) J Periodontal Res. 2011;46:261–8.
    1. Heasman PA, Benn DK, Kelly PJ, Seymour RA, Aitken D. The use of topical flurbiprofen as an adjunct to non-surgical management of periodontal disease. J Clin Periodontol. 1993;20:457–64.
    1. Williams RC, Jeffcoat MK, Kaplan ML, Goldhaber P, Johnson HG, Wechter WJ. Flurbiprofen: A potent inhibitor of alveolar bone resorption in beagles. Science. 1985;227:640–2.
    1. Heasman PA, Collins JG, Offenbacher S. Changes in crevicular fluid levels of interleukin-1 beta, leukotriene B4, prostaglandin E2, thromboxane B2 and tumour necrosis factor alpha in experimental gingivitis in humans. J Periodontal Res. 1993;28:241–7.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren